Immunocyt: A new tool for detecting transitional cell cancer of the urinary tract

Journal of Urology

Volumn 161, Issue 5, 1999, Pages 1486-1489

  Mian, Christine ^a   Pycha, Armin ^a   Wiener, Helene ^a   Haitel, Andrea ^a   Lodde, Michele ^a   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer, transitional cell; Cytology; Immunofluorescence; Monoclonal antibody; Urinary tract

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINARY TRACT CANCER;

EID: 0032874431     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68934-3     Document Type: Article

References (16)

1. Wiener, H. G., Mian, C., Haitel, A., Pycha, A., Schatzl, G. and Marberger, M.: Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J. Urol., 159: 1876, 1998.
2. Chopin, D. K. and Laurent, J. C.: Monoclonal antibodies in bladder cancer cytology. World J. Urol., 9: 75, 1991.
3. Fradet, Y. and Cordon-Cardo, C.: Critical appraisal of tumor markers in bladder cancer. Sem. Urol., 11: 145, 1993.
4. Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing E., Pasciak, R. M., Reservitz, G. B., Rukstalis, D. B., Sarosdy, M. F., Stadler, W. M., Thiel, R. P. and Hayden, C. L.: Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol., 156: 363, 1996.
5. Kavaler, E., Shu, W.-P., Chang, Y., Droller, M. J. and Liu, B. C.-S.: Detection of human bladder cancer cells in voided urine samples by assaying the presence of telomerase activity. J. Urol., part 2, 157: 338, abstract 321, 1997.
6. Klein, A., Zemer, R., Buchumensky, V., Klaper, R., Nissenkorn, I. and Saba, K.: Detection of bladder carcinoma: a urine test, based on cytokeratin expression. J. Urol., part 2, 157: 339, abstract 1336, 1997.
7. Sarosdy, M. F., Hudson, M. A., Ellis, W. J., Soloway, M. S., deVere White, R. W., Sheinfield, J., Jarowenko, M. V., Schellhammer, P. F., Shervish, E. W., Patel, J. V., Chodak, G. W., Lamm, D. L., Johnson, R. D., Henderson, M., Adams, G., Blumenstein, B. A., Thoelke, K. R., Pfalzgraf, R. D., Murchison, H. A. and Brunelle, S. L.: Improved detection of recurrent bladder cancer using the Bard BTA stat test. Urology, 50: 349, 1997.
8. Leyh, H., Marberger, M., Pagano, P., Bassi, P., Sternberg, C. N., Pansadoro, V., Conort, P., Boccon-Gibod, L. and Thoelke, K. R.: Results of a European multicenter trial comparing the BTA stat-test to urine cytology in patients suspected of having bladder cancer. J. Urol., part 2, 157: 337, abstract 1316, 1997.
9. Ishak, L. M., Enfield, D. L., Sarosdy, M. F. and Multicenter Group.: Detection of recurrent bladder cancer using a new quantitative assay for bladder tumor antigen. J. Urol., part 2, 157: 337, abstract 1317, 1997.
10. Fradet, Y. and Lockhart, C.: Performance characteristics of a new monoclonal antibody test for bladder cancer: Immunocyt™. Canad. J. Urol., 4: 400, 1997.
11. Fradet, Y., La Rue, H., Parent-Vaugeois, C., Bergeron, A., Dufour, C. and Boucher, L.: Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas. Int. J. Cancer, 46: 990, 1990.
12. Bergeron, A., Champetier, S., LaRue, H. and Fradet, Y.: MAUB is a new mucin antigen associated with bladder cancer. J. Biol. Chem., 271: 6933, 1996.
13. Sobin, L. H. and Wittekind, C.: TNM Classification of Malignant Tumours, 5th ed. International Union Against Cancer. New York: Springer-Verlag, 1997.
14. Koss, L. G., Deitch, D., Ramanathan, R. and Sherman, A. B.: Diagnostic value of cytology of voided urine. Acta Cytol., 29: 810, 1985.
15. Fraser, R. A., Ravry, M. J., Segura, J. W. and Go, V. L. W.: Clinical evaluation of urinary and serum carcino-embryogenic antigen in bladder cancer. J. Urol., 114: 226, 1975.
16. Myanaga, N., Akaza, H., Ishikawa, S., Ohtani, M., Noguchi, R., Kawai, K., Koiso, K., Kobayashi, M., Koyama, A. and Takahashi, T.: Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur. Urol., 31: 163, 1997.